Bumetanide Injection — FDA Drug Shortage

Resolved — Sagent Pharmaceuticals

The FDA lists a drug shortage record for Bumetanide Injection (injection) from Sagent Pharmaceuticals with status Resolved. The shortage was first posted on Jan 31, 2018.

Shortage details

Status
Resolved
Company
Sagent Pharmaceuticals
Package NDC
25021-321-04
Dosage Form
Injection
Presentation
Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04)
Initial Posting
Jan 31, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.